5.500
+0,00%
2026-10-15
Fundamental Analysis
72 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +255.0% | +204.9% | 3 / 3 | +15.7% | +4.01 pp | +3.13 pp | +5.7% | 1.38 | 5.94 | 319 | +15,7% | 7,6 | +480,5% | 5.94 | 2.59 | +129,2% |
| Pts | 12 | 12 | 12 | 8 | 12 | 12 | 0 | 6 | 4 | |||||||
Valuation annotation:Price: 5.500 (close price on 2026-10-15)EPS (TTM): 926,5
Financial charts
1.Revenue & growth
VND bn318Q2/26
1.Revenue & growth
VND bn318Q2/26
2.Profit & growth
VND bn5,83Q2/26
3.Profit mix (Penman)
VND bn28,8Q2/26
4.Margins & cost structure
%13.4%Q2/26
5.Returns & cash cycle
% · days7.5%Q2/26
6.Earnings quality & cash
VND bn133Q2/26
7.Asset structure
VND bn1.136Q2/26
8.Funding & debt health
VND bn · times1.136Q2/26
9.Revenue backlog
VND bn29,9Q2/26
10.Valuation
times · %5,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %285Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
21.5%
averaged over 1 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26